Home › Compare › LICH vs MRK

LICH vs MRK: Dividend Comparison 2026

LICH yields 35087.72% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LICH wins by $1.4045583093529018e+22M in total portfolio value
10 years
LICH
LICH
● Live price
35087.72%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4045583093529018e+22M
Annual income
$13,967,277,210,808,802,000,000,000,000.00
Full LICH calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — LICH vs MRK

📍 LICH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLICHMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LICH + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LICH pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LICH
Annual income on $10K today (after 15% tax)
$2,982,456.14/yr
After 10yr DRIP, annual income (after tax)
$11,872,185,629,187,480,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, LICH beats the other by $11,872,185,629,187,480,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LICH + MRK for your $10,000?

LICH: 50%MRK: 50%
100% MRK50/50100% LICH
Portfolio after 10yr
$7.022791546764509e+21M
Annual income
$6,983,638,605,404,401,000,000,000,000.00/yr
Blended yield
99.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LICH
No analyst data
Altman Z
-3980.7
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LICH buys
0
MRK buys
0
No recent congressional trades found for LICH or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLICHMRK
Forward yield35087.72% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$1.4045583093529018e+22M$30.7K ✓
Annual income after 10y$13,967,277,210,808,802,000,000,000,000.00 ✓$950.29
Total dividends collected$1.4040435209834525e+22M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LICH vs MRK ($10,000, DRIP)

YearLICH PortfolioLICH Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$3,519,472$3,508,771.93$11,192$351.54+$3.51M → LICH
2$1,157,880,257$1,154,114,421.98$12,524$392.70+$1157.87M → LICH
3$356,094,180,688$354,855,248,813.21$14,015$438.65+$356094.17M → LICH
4$102,373,625,569,446$101,992,604,796,109.58$15,682$489.96+$102373625.55M → LICH
5$27,513,170,932,649,252$27,403,631,153,289,944.00$17,547$547.23+$27513170932.63M → LICH
6$6,912,425,278,424,497,000$6,882,986,185,526,563,000.00$19,632$611.16+$6912425278424.48M → LICH
7$1,623,550,972,939,442,000,000$1,616,154,677,891,527,600,000.00$21,963$682.53+$1623550972939442.00M → LICH
8$356,497,181,763,681,700,000,000$354,759,982,222,636,500,000,000.00$24,571$762.18+$356497181763681664.00M → LICH
9$73,183,067,962,816,976,000,000,000$72,801,615,978,329,840,000,000,000.00$27,486$851.08+$73183067962816978944.00M → LICH
10$14,045,583,093,529,017,000,000,000,000$13,967,277,210,808,802,000,000,000,000.00$30,745$950.29+$1.4045583093529018e+22M → LICH

LICH vs MRK: Complete Analysis 2026

LICH — Stock

LIVECHAIN INC., a tech technology company, engages in the development and distribution of live streaming technology and applications of public chain technology. The company is based in Reno, Nevada.

Full LICH Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this LICH vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LICH vs SCHDLICH vs JEPILICH vs OLICH vs KOLICH vs MAINLICH vs JNJLICH vs ABBVLICH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.